Hotel Panchavati & Anr. v. Hotel Panchvati & Anr.

COMMERCIAL IP SUIT (L) NO.234 OF 2019

The Bombay High Court granted ad-interim relief in a trademark infringement and passing off suit filed by Hotel Panchavati & Anr. The court recognized the Plaintiffs' well-known reputation and goodwill associated with the 'PANCHAVATI' marks in the hospitality sector. Finding that the Defendants were using deceptively similar marks and domain names, the Court issued an injunction restraining their continued use of these marks and directed them to remove all infringing materials within three days.

Jurisdiction
India
Court
Bombay High Court
Case Number
COMMERCIAL IP SUIT (L) NO.234 OF 2019
Judge(s)
S.J. Kathawalla

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Bombay High Court. Understanding the court's reasoning in Hotel Panchavati & Anr. vs Hotel Panchvati & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentW.P.A. 12041 of 2023

Jayshree & CompanyvsThe State Of West Bengal & Ors

Jayshree & Company challenged a notice issued by respondents restricting the registration of their echo friendly e-rickshaws. The restriction was based on an order in a Title Suit where a fuel cell battery manufacturer alleged patent infringement. The court ruled in favor of the petitioner, directing authorities to grant registration provided the vehicles are distinct from those in the ongoing suit.

patent(T) CMA(PT) No.41 of 2023

Ibrum TechnologiesvsThe Controller of Patents

Ibrum Technologies appealed the dismissal of its patent application for an Intelligent Indoor Air Quality Monitoring System. The rejection was based on non-compliance with various sections of the Patents Act, but the appellant argued that the Controller's proceedings were flawed because their oral submissions were interrupted mid-argument. The Madras High Court allowed the appeal and remanded the matter back to the Controller.

patentCivil Appeal No. 9491 of 2019

M/s Genentech Inc.vsDrugs Controller General Of India

Genentech Inc. appealed an interim order passed by the Delhi High Court which had altered the protective conditions previously set by the Single Judge concerning the launch of the biosimilar drug 'TrastuRel' (manufactured by Reliance Life Sciences Pvt. Ltd.). The dispute centered on Genentech's patent rights over the monoclonal antibody drug 'Trastuzumab'.

patentC.O. (COMM.IPD-TM) 667/2022 and connected matters

M/S P.M. Diesels P. Ltd.vsM/S Thukral Mechanical Works & Ors.

In a complex 40-year dispute over the 'FIELDMARSHAL' trademark, the Delhi High Court ruled in favor of M/S P.M. Diesels Pvt. Ltd. The court set aside previous orders from the IPAB that had rejected P.M. Diesels' applications and cancelled a key registration held by Thukral Mechanical Works. This landmark decision allows P.M. Diesels to proceed with registering its mark, effectively resolving a long-standing conflict over brand ownership in the diesel engine sector.

patentCS(COMM) 425/2020

Novartis AgvsTorrent Pharmaceuticals Limited

The Plaintiffs filed a suit for infringement of Indian Patent No. 229051, while the Defendant challenged the validity of the patent. The parties amicably resolved their disputes and sought a consent decree.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call